LEADER 04385nam 2200601 450 001 9910819608903321 005 20230803204640.0 010 $a0-309-28813-4 010 $a0-309-28811-8 035 $a(CKB)3710000000229408 035 $a(EBL)3379351 035 $a(SSID)ssj0001424118 035 $a(PQKBManifestationID)12547907 035 $a(PQKBTitleCode)TC0001424118 035 $a(PQKBWorkID)11446912 035 $a(PQKB)10353878 035 $a(MiAaPQ)EBC3379351 035 $a(Au-PeEL)EBL3379351 035 $a(CaPaEBR)ebr10924429 035 $a(OCoLC)899280083 035 $a(EXLCZ)993710000000229408 100 $a20140912h20142014 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aImproving access to essential medicines for mental, neurological, and substance use disorders in Sub-Saharan Africa $eworkshop summary : forum on neuroscience and nervous system disorders /$fBoard on Health Sciences Policy, Board on Global Health ; Diana E. Pankevich, rapporteurs [and three others] 210 1$aWashington, District of Columbia :$cThe National Academies Press,$d2014. 210 4$dİ2014 215 $a1 online resource (143 p.) 300 $aDescription based upon print version of record. 311 $a0-309-28810-X 327 $a""Front Matter""; ""Reviewers""; ""Contents""; ""1 Introduction and Overview""; ""2 Challenge: Insufficient Demand""; ""3 Challenge: Inappropriate Selection""; ""4 Challenge: Ineffective Supply Chains""; ""5 Challenge: High Pricing and Poor Financing""; ""6 Perspectives on Next Steps""; ""Appendix A: Access to Essential Medicines: Program Examples""; ""Appendix B: References""; ""Appendix C: Workshop Agenda""; ""Appendix D: Registered Attendees"" 330 $a"In 2011 the Grand Challenges in Global Mental Health initiative identified priorities that have the potential to make a significant impact on the lives of people with mental, neurological, and substance use disorders. Reduction of the cost and improvement of the supply of effective medicines was highlighted as one of the top five challenges. For low- and middle-income countries, improving access to appropriate essential medicines can be a tremendous challenge and a critical barrier to scaling up quality care for mental, neurological, and substance use disorders. Reduction of cost and improvement of the supply of effective medicines has the potential to significantly impact the lives of patients with these disorders. Improving Access to Essential Medicines for Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa is the summary of a workshop convened by the Institute of Medicine Neuroscience Forum in January 2014 in Addis Ababa, Ethiopia to discuss opportunities for achieving long-term affordable access to medicines for these disorders. This report examines challenges and opportunities for improving access to essential medicines in four critical areas: demand, selection, supply chains, and financing and pricing. The report also discusses successful activities that increase access to essential medicines both within Sub-Saharan Africa and in other developing countries, and considers the role of governments, nongovernmental organizations, and private groups in procurement of essential medicines for mental, neurological, and substance use disorders."--$cPublisher's description. 606 $aPsychology, Pathological$xdrug therapy 606 $aNervous System Diseases$xdrug therapy$vCongresses 606 $aMental illness$xdrug therapy 615 0$aPsychology, Pathological$xdrug therapy. 615 0$aNervous System Diseases$xdrug therapy 615 0$aMental illness$xdrug therapy. 676 $a616.8918 700 $aPankevich$b Diana E.$f1975-$01596033 702 $aPankevich$b Diana E. 712 02$aInstitute of Medicine (U.S.).$bBoard on Global Health, 712 12$aImproving Access to Essential Medicines for Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa (Workshop)$f(2014 :$eAddis Ababa, Ethiopia) 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910819608903321 996 $aImproving access to essential medicines for mental, neurological, and substance use disorders in Sub-Saharan Africa$93917203 997 $aUNINA